Occupe actuellement des postes chez Oncopeptides AB and Gilead Sciences Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Oncopeptides AB | 17 mai 2018 - |
Independent Director | Gilead Sciences Inc | 28 janvier 2010 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-04-24 | 2024-04-19 |
Oncopeptides AB
(ONCO)
|
A Achat |
204 664
2,60532 126 SEK |
204 664 | 2,60 | 532 126 SEK | |
2024-04-19 | 2024-04-19 |
Oncopeptides AB
(ONCO)
|
A Achat |
204 664
2,60532 126 SEK |
204 664 | 2,60 | 532 126 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
1 000
27,1627 160 SEK |
1 000 | 27,16 | 27 160 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
250
27,136 783 SEK |
250 | 27,13 | 6 783 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
115
27,103 117 SEK |
115 | 27,10 | 3 117 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
500
27,0913 545 SEK |
500 | 27,09 | 13 545 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
480
26,9512 936 SEK |
480 | 26,95 | 12 936 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
176
26,954 743 SEK |
176 | 26,95 | 4 743 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
600
26,8916 134 SEK |
600 | 26,89 | 16 134 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
443
27,0011 961 SEK |
443 | 27,00 | 11 961 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
20
27,00540 SEK |
20 | 27,00 | 540 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
2 050
27,0055 350 SEK |
2 050 | 27,00 | 55 350 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
1 702
26,9445 852 SEK |
1 702 | 26,94 | 45 852 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
1 211
26,9332 612 SEK |
1 211 | 26,93 | 32 612 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
2 000
26,9253 840 SEK |
2 000 | 26,92 | 53 840 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
1 000
26,9126 910 SEK |
1 000 | 26,91 | 26 910 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
20
26,90538 SEK |
20 | 26,90 | 538 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
1 700
26,9045 730 SEK |
1 700 | 26,90 | 45 730 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
A Achat |
1 029
26,8927 670 SEK |
1 029 | 26,89 | 27 670 SEK | |
2022-01-12 | 2022-01-12 |
Oncopeptides AB
(ONCO)
|
A Achat |
185 540
7,601 410 898 SEK |
185 540 | 7,60 | 1 410 898 SEK | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Vente |
6 600
-3.7%
35,08231 528 USD |
6 600 -3.7% | 35,08 | 231 528 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Vente |
3 600
-2.0%
35,05126 180 USD |
3 600 -2.0% | 35,05 | 126 180 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Vente |
24 800
-11.9%
35,03868 744 USD |
24 800 -11.9% | 35,03 | 868 744 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Vente |
35 000
-14.4%
35,011 225 350 USD |
35 000 -14.4% | 35,01 | 1 225 350 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Vente |
24 949
-9.3%
35,00873 215 USD |
24 949 -9.3% | 35,00 | 873 215 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Vente |
7 500
-4.2%
45,19338 925 USD |
7 500 -4.2% | 45,19 | 338 925 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Vente |
5 000
-2.7%
45,18225 900 USD |
5 000 -2.7% | 45,18 | 225 900 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Vente |
15 000
-7.5%
45,13676 950 USD |
15 000 -7.5% | 45,13 | 676 950 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Vente |
7 500
-3.6%
45,10338 250 USD |
7 500 -3.6% | 45,10 | 338 250 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Vente |
5 000
-2.3%
45,04225 200 USD |
5 000 -2.3% | 45,04 | 225 200 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Vente |
16 400
-7.2%
45,03738 492 USD |
16 400 -7.2% | 45,03 | 738 492 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Vente |
10 000
-4.2%
45,20452 000 USD |
10 000 -4.2% | 45,20 | 452 000 USD |